Cian McCourt

Cian is a partner and Head of the Corporate and M&A Group. Cian specialises in mergers and acquisitions, advising on public and private transactions as well as corporate finance and equity capital markets transactions.

Cian has experience advising on domestic and cross border transactions in a number of industries including the pharma/healthcare, financial services, energy and technology sectors as well as advising on corporate migrations, holding company structures, schemes of arrangement and cross border mergers. Cian has extensive experience in public M&A and has advised international clients and boards of directors on investing in Ireland and Irish based acquisitions including advising on some of the largest and most high profile public transactions in Irish corporate history. Prior to joining Arthur Cox Cian was a partner in another leading Irish law firm and spent a number of years based in London and New York.

Relevant Experience

• Advising Allergan plc on its pending $63 billion merger with AbbVie
• Advising Mediahuis NV on its €145.6 million recommended offer for Independent News & Media plc
• Advising Aryzta A.G. on its €800 million underwritten rights issue and the resulting admission of shares on the SIX Swiss Exchange and Euronext Dublin
• Advising Praxair, Inc. on its $70 billion merger of equals with Linde A.G. and the admission of Linde plc to the NYSE and the main market in Frankfurt
• Advising Greencore Group plc on its sale of Greencore US for $1,075 million and related £509 million share repurchase/tender offer
• Advising Medtronic plc on its acquisition of Irish medtech firm Crospon Limited
• Advising Allied Irish Banks, p.l.c. on its investment in Irish fintech firm TransferMate Limited
• Advising Bank of Ireland on its reorganisation and establishment of its new holding company, Bank of Ireland Group plc
• Advising Greencore Group plc on its $747.5 million acquisition of Peacock Foods and related £440 million rights issue
• Advising Medtronic Inc. on its $49 billion acquisition of Covidien plc and related re-domiciliation to Ireland